However, this vascular monitoring has yet to be investigated in the context of LV remodeling following reperfused acute MI and where patients are commonly referred to hypotensive medical regimens (angiotensin converting enzyme (ACE) inhibitors, beta-blockers). The gene discussed is ACE; the disease is myocardial infarction.